Innate immunity in atopic dermatitis

Current Problems in Dermatology

Volumn 41, Issue , 2011, Pages 104-111

  Mrabet Dahbi, S ^a   Maurer, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; MEMBRANE PROTEIN; PATTERN RECOGNITION RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL CLEARANCE; BODY TEMPERATURE; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL FUNCTION; CYTOKINE PRODUCTION; HUMAN; HUMAN GENOME; INNATE IMMUNITY; KERATINOCYTE; MONOCYTE; MUTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; STRATUM CORNEUM; TH1 CELL;

ALCOHOL OXIDOREDUCTASES; ANTIMICROBIAL CATIONIC PEPTIDES; CYTOKINES; DERMATITIS, ATOPIC; HUMANS; IMMUNITY, INNATE; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASES, INFECTIOUS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS;

EID: 84925944318     PISSN: 14215721     EISSN: 16622944     Source Type: Book Series    
DOI: 10.1159/000323304     Document Type: Article

References (51)

1. Elias PM: Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005;125: 183-200. (Pubitemid 41648149)
2. Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ: Keratinocytes as initiators of inflammation. Lancet 1991;337:211-214.
3. Goodarzi H, Trowbridge J, Gallo RL: Innate immunity: a cutaneous perspective. Clin Rev Allergy Immunol 2007;33:15-26.
4. Pivarcsi A, Keḿny L, Dobozy A: Innate immune functions of the keratinocytes: a review. Acta Microbiol Immunol Hung 2004;51:303-310. (Pubitemid 39531640)
5. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002;20:197-216. (Pubitemid 34293424)
6. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003;21:335-76. (Pubitemid 37174535)
7. Beutler B, Hoebe K, Du X, Ulevitch RJ: How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 2003; 74:479-485. (Pubitemid 38040374)
8. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway CA Jr: MyD88 is an adaptor protein in the hToll/IL-1 receptor family signalling pathways. Mol Cell 1998;2:253-258. (Pubitemid 128373651)
9. Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A: The human Toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptorassociated factor 6 (TRAF6). J Exp Med 1998;187: 2097-2101. (Pubitemid 28285580)
10. Baud V, Liu ZG, Bennett B, Suzuki N, Xia Y, Karin M: Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev 1999;13:1297-1308. (Pubitemid 29250197)
11. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A: The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000;97:13766-13771.
12. Harton JA, Linhoff MW, Zhang J, Ting JP: Cutting edge: CATERPILLER-a large family of mammalian genes containing CARD, pyrin, nucleotidebinding, and leucine-rich repeat domains. J Immunol 2002;169:4088-4093. (Pubitemid 35178175)
13. Martinon F, Tschopp J: NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005;26: 447-454. (Pubitemid 41008082)
14. Wollenberg A, Mommaas M, Oppel T, Schottdorf EM, Gther S, Moderer M: Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J Invest Dermatol 2002;118:327-334. (Pubitemid 34158489)
15. Takeuchi O, Akira S: Recognition of viruses by innate immunity. Immunol Rev 2007;220: 214-224. (Pubitemid 350045565)
16. Lidington EA, McCormack AM, Yacoub MH, Rose ML: The effects of monocytes on the transendothelial migration of T lymphocytes. Immunology 1998;94:221-227. (Pubitemid 28267478)
17. Labow M, Shuster D, Zetterstrom M, Nunes P, Terry R, Cullinan EB, Bartfai T, Solorzano C, Moldawer LL, Chizzonite R, McIntyre KW: Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J Immunol 1997; 159:2452-2461. (Pubitemid 127681040)
18. Dinarello CA: IL-18: a Th1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999;103:11-24. (Pubitemid 29063184)
19. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001;194:519-527. (Pubitemid 32835046)
20. Izadpanah A, Gallo RL: Antimicrobial peptides. J Am Acad Dermatol 2005;52:381-392.
21. Pivarcsi A, Bodai L, Ŕthi B, Kenderessy-SzabA, Koreck A, Sźll M, Beer Z, Bata-Csgoo Z, Magsi M, Rajnavgyi E, Dobozy A, Keḿny L: Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003;15:721-730. (Pubitemid 36675803)
22. Mempel M, Voelcker V, Klisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli AK, Ring J, Abeck D, Ollert M: Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is Toll-like receptor 2 but not Toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 2003;121:1389-1396. (Pubitemid 38005491)
23. Strober W: Epithelial cells pay a Toll for protection. Nat Med 2004;10:898-900. (Pubitemid 39273724)
24. Fukao T, Koyasu S: PI3K and negative regulation of TLR signaling. Trends Immunol 2003;24:358-363. (Pubitemid 36830961)
25. Otte JM, Cario E, Podolsky DK: Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004;126:1054-1070. (Pubitemid 38451177)
26. Rippke F, Schreiner V, Doering T, Maibach HI: Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus. Am J Clin Dermatol 2004;5: 217-223. (Pubitemid 39127965)
27. Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G: Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 2002; 119:433-439. (Pubitemid 35001954)
28. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, Di Giovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-446.
29. Henderson J, Northstone K, Lee SP, Liao H, Zhao Y, Pembrey M, Mukhopadhyay S, Smith GD, Palmer CN, McLean WH, Irvine AD: The burden of disease associated with filaggrin mutations: a populationbased, longitudinal birth cohort study. J Allergy Clin Immunol 2008;121:872-877.
30. Brown SJ, Relton CL, Liao H, Zhao Y, Sandilands A, Wilson IJ, Burn J, Reynolds NJ, McLean WH, Cordell HJ: Filaggrin null mutations and childhood atopic eczema: a population-based case-control study. J Allergy Clin Immunol 2008;121:940-946.
31. Rice NE, Patel BD, Lang IA, Kumari M, Frayling TM, Murray A, Melzer D: Filaggrin gene mutations are associated with asthma and eczema in later life. J Allergy Clin Immunol 2008;122:834-836.
32. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A: Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ('epidermal differentiation complex') on human chromosome 1q21. J Invest Dermatol 1996;106:989-992.
33. Candi E, Schmidt R, Molino G: The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005;6:328-340. (Pubitemid 40516899)
34. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY: Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007;120:150-155. (Pubitemid 46990506)
35. Howell MD, Fairchild HR, Kim BE, Bin L, Boguniewicz M, Redzic JS, Hansen KC, Leung DY: Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008; 128:1591-1594.
36. Katsuta M, Takigawa Y, Kimishima M, Inaoka M, Takahashi R, Shiohara T: NK cells and ãä+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis. J Immunol 2006;176:7736-7744. (Pubitemid 43849074)
37. Rogge JL, Hanifin JM: Immunodeficiencies in severe atopic dermatitis: depressed chemotaxis and lymphocyte transformation. Arch Dermatol 1976; 112:1391-1396.
38. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S: Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999;11:443-451. (Pubitemid 29504199)
39. Hasannejad H, Takahashi R, Kimishima M, Hayakawa K, Shiohara T: Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis. J Allergy Clin Immunol 2007;120:69-75. (Pubitemid 46990500)
40. McGirt LY, Beck LA: Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 2006;118: 202-208. (Pubitemid 43946481)
41. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA: A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68:6398-6401.
42. Mrabet-Dahbi S, Ahmad-Nejad P, Breuer K, Klotz M, Werfel T, Herz U, et al: The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004;113:565-567. (Pubitemid 38338967)
43. Mrabet-Dahbi S, Dalpke AH, Niebuhr M, Frey M, Draing C, Brand S, et al: The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol 2008;121:1013-1019.
44. Shimizu M, Matsuda A, Yanagisawa K, Hirota T, Akahoshi M, Inomata N, Ebe K, Tanaka K, Sugiura H, Nakashima K, Tamari M, Takahashi N, Obara K, Enomoto T, Okayama Y, Gao PS, Huang SK, Tominaga S, Ikezawa Z, Shirakawa T: Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. Hum Mol Genet 2005;14:2919-2927. (Pubitemid 41418796)
45. Zhang G, Ghosh S: Negative regulation of Toll-like receptor-mediated signaling by Tollip. J Biol Chem 2002;277:7059-7065. (Pubitemid 34953094)
46. Didierlaurent A, Brissoni B, Velin D, Aebi N, Tardivel A, K̈slin E, Sirard JC, Angelov G, Tschopp J, Burns K: Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol Cell Biol 2006;26:735-742. (Pubitemid 43146471)
47. Schimming TT, Parwez Q, Petrasch-Parwez E, Nothnagel M, Epplen JT, Hoffjan S: Association of Toll-interacting protein gene polymorphisms with atopic dermatitis. BMC Dermatol 2007;7:3.
48. Matsui E, Kaneko H, Teramoto T, Fukao T, Inoue R, Kasahara K, et al: Reduced IFN-ã production in response to IL-12 stimulation and/or IL-12 production in atopic patients. Clin Exp Allergy 2000;30: 1250-1256.
49. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-1160.
50. Howell MD, Boguniewicz M, Pastore S, Novak N, Bieber T, Girolomoni G, et al: Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol 2006; 121:332-338. (Pubitemid 44768007)
51. Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE, et al: Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006;24: 341-348.